Should I buy or sell Genomma Lab Internacional stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genomma Lab Internacional in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" GNMLF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GNMLF, but not buy additional shares or sell existing shares. View GNMLF analyst ratings or view top-rated stocks .

How have GNMLF shares performed in 2024?

Genomma Lab Internacional's stock was trading at $0.8399 at the start of the year. Since then, GNMLF shares have increased by 16.6% and is now trading at $0.9794. View the best growth stocks for 2024 here .

Are investors shorting Genomma Lab Internacional?

Genomma Lab Internacional saw a increase in short interest during the month of June. As of June 15th, there was short interest totaling 3,153,000 shares, an increase of 28.9% from the May 31st total of 2,445,800 shares. Based on an average trading volume of 800 shares, the short-interest ratio is presently 3,941.3 days. View Genomma Lab Internacional's Short Interest .

How do I buy shares of Genomma Lab Internacional?

Shares of GNMLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:GNMLF

Genomma Lab Internacional (GNMLF) Stock Price, News & Analysis

$0.98

0.00 (0.00%)

(As of 07/3/2024 ET)

Compare

Today's Range: $0.98
▼
$0.98
50-Day Range: $0.92
▼
$0.98
52-Week Range: $0.79
▼
$0.99

Volume: N/A
Average Volume: 9,910 shs
Market Capitalization: N/A

P/E Ratio: 0.58
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Analyst Forecasts Chart Short Interest

Get Genomma Lab Internacional alerts:

Ad Paradigm Press

Elon Musk: THIS will be bigger than Tesla

If you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you must get in now. Don’t delay.

See all the details you need here.

About Genomma Lab Internacional

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Latin America. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and sexual improvement, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, and infant nutrition. The company was incorporated in 1996 and is based in Mexico City, Mexico.

GNMLF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

GNMLF Stock News Headlines

July 2 at 3:33 PM | prnewswire.com

Genomma Lab Internacional S.A.B. de C.V. Second Quarter 2024 Earnings Results Conference Call

June 13, 2024 | prnewswire.com

GENOMMA LAB INTERNACIONAL ANNOUNCES EIGHTH DIVIDEND PAYMENT

July 3, 2024 | Behind the Markets (Ad)

[BUY ALERT] “This Could Be Worth 28X More than NVIDIA”

This firm's stock is currently trading for only $15. But that won't last long. Because even OpenAI founder Sam Altman admits AI "depends" on this firm's work.

April 24, 2024 | prnewswire.com

Genomma Lab Internacional Announces Results for the First Quarter 2024

March 13, 2024 | prnewswire.com

GENOMMA LAB INTERNACIONAL ANNOUNCES SEVENTH DIVIDEND PAYMENT

February 28, 2024 | prnewswire.com

Genomma Lab's ESG Rating Upgraded to A

February 21, 2024 | prnewswire.com

Genomma Lab Internacional Reports Fourth Quarter & Full Year 2023 Results

October 4, 2023 | prnewswire.com

Genomma Lab Internacional S.A.B. de C.V. Third Quarter 2023 Earnings Results Conference Call

See More Headlines

Receive GNMLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genomma Lab Internacional and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Current Symbol: OTCMKTS:GNMLF
CUSIP: N/A
CIK: N/A
Web: www.genommalab.com
Phone: 525550810000
Fax: N/A
Employees: 1,783
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 0.58
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Mr. Juan Marco Sparvieri
Chief Executive Officer
Engineer Antonio Zamora Galland
Executive VP of Finance & Administration and CFO
Daniel Suarez Neria
Head of Investor Relations
Mr. Alejandro Bastón Patiño
Executive Vice President of Institutional Relations, Media, Human Resources & Sustainability

Key Competitors

View All Competitors

GNMLF Stock Analysis - Frequently Asked Questions

Should I buy or sell Genomma Lab Internacional stock right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genomma Lab Internacional in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" GNMLF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GNMLF, but not buy additional shares or sell existing shares.
View GNMLF analyst ratings or view top-rated stocks.
How have GNMLF shares performed in 2024?: Genomma Lab Internacional's stock was trading at $0.8399 at the start of the year. Since then, GNMLF shares have increased by 16.6% and is now trading at $0.9794.
View the best growth stocks for 2024 here.
Are investors shorting Genomma Lab Internacional?: Genomma Lab Internacional saw a increase in short interest during the month of June. As of June 15th, there was short interest totaling 3,153,000 shares, an increase of 28.9% from the May 31st total of 2,445,800 shares. Based on an average trading volume of 800 shares, the short-interest ratio is presently 3,941.3 days.
View Genomma Lab Internacional's Short Interest.
How do I buy shares of Genomma Lab Internacional?: Shares of GNMLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.